On behalf of FDA Commissioner Marty Makary, M.D., M.P.H., the FDA is holding a series of roundtable discussions with independent panels of scientific experts that will review the latest scientific evidence, evaluate potential health risks, explore safer alternatives, and may offer recommendations for regulatory action. This initiative is part of the FDA’s broader efforts to apply| RxISK - Making Medicines Safer for All of Us
Epidemiology deals in correlations that are subject to confounding. Think tobacco and lung cancer. Although studies should attempt to account for confounding, confounding can also be exploited to explain away inconvenient data as tobacco company claims that correlations do not prove causation illustrated. This underpinned the famous Doubt is our Product tobacco company strategy, which| RxISK - Making Medicines Safer for All of Us
I took part in a podcast recently at the invitation of John Wilks and Our Birth Journey a group John is linked to. Our conversation is on this link: Antidepressants and Acetaminophen Use During Pregnancy The title says Antidepressants and Acetaminophen (U.S. for Paracetamol). The original invite was to talk about Antidepressants and Pregnancy. The| RxISK - Making Medicines Safer for All of Us
In 2023 a new set of Canadian Guidelines for the Management of Alcohol Use Disorders put a serious problem on the radar for doctors that few of them likely expected. See Antidepressants, Alcohol and Anne-Marie. The antidepressants doctors commonly prescribed, often telling people these medicines would help them manage their alcohol issues, were likely causing| RxISK - Making Medicines Safer for All of Us